Administration of recombinant human stem cell factor (rhSCF) and granulocyte-colony stimulating factor (rhG-CSF) to maternal and fetal rhesus monkeys (Macaca mulatta)

Alice F Tarantal, Morton J. Cowan

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Studies with recombinant human stem cell factor (rhSCF) and granulocyte-colony stimulating factor (rhG-CSF) have suggested significant clinical utility although little is known regarding the effect of these cytokines when administered during pregnancy. rhSCF (25 ug/kg/day) ± rhG-CSF (50 μg/kg/day) were administered chronically to gravid rhesus monkeys (n = 12) or directly to the rhesus fetus (n = 2) during the second and third trimesters. Maternal/fetal blood samples were collected to assess circulating SCF/G-CSF levels and complete blood counts compared to non-treated animals (n = 40). Fetal endogenous SCF levels were four-fold greater than the dam (fetus ~ 2500 pg/ml, dam ~ 500 pg/ml), whereas circulating G-CSF was similar in the fetal/maternal compartments (~ 50-100 pg/ml). There were no adverse effects detected in the fetus or dam as a result of SCF ± G-CSF administration. Although high levels of SCF and G-CSF were achieved in the maternal circulation with maternal administration (SCF: 7000-15,000 pg/ml; G-CSF: 7000-54,000 pg/ml), there was little evidence of placental transport or effects on fetal haematopoiesis. In contrast, direct fetal administration of SCF + G-CSF resulted in a rapid rise in fetal neutrophil counts. These studies have shown the monkey to be an excellent model for studying haematopoietic interventions during gestation, and suggest the best approach for achieving haematopoietic changes in the fetus and newborn is by direct in utero administration.

Original languageEnglish (US)
Pages (from-to)290-300
Number of pages11
JournalCytokine
Volume11
Issue number4
DOIs
StatePublished - 1999

Fingerprint

Stem Cell Factor
Granulocyte Colony-Stimulating Factor
Macaca mulatta
Mothers
Fetus
Dams
Blood
Pregnancy
Blood Cell Count
Hematopoiesis
Third Pregnancy Trimester
Second Pregnancy Trimester
Fetal Blood
Haplorhini
Animals
Neutrophils
Cytokines

Keywords

  • Fetus
  • G-CSF
  • Haematopoiesis
  • Monkey
  • SCF

ASJC Scopus subject areas

  • Endocrinology
  • Molecular Biology
  • Immunology
  • Immunology and Allergy

Cite this

@article{b978095b748a4def9c10fd5d43c3b8b5,
title = "Administration of recombinant human stem cell factor (rhSCF) and granulocyte-colony stimulating factor (rhG-CSF) to maternal and fetal rhesus monkeys (Macaca mulatta)",
abstract = "Studies with recombinant human stem cell factor (rhSCF) and granulocyte-colony stimulating factor (rhG-CSF) have suggested significant clinical utility although little is known regarding the effect of these cytokines when administered during pregnancy. rhSCF (25 ug/kg/day) ± rhG-CSF (50 μg/kg/day) were administered chronically to gravid rhesus monkeys (n = 12) or directly to the rhesus fetus (n = 2) during the second and third trimesters. Maternal/fetal blood samples were collected to assess circulating SCF/G-CSF levels and complete blood counts compared to non-treated animals (n = 40). Fetal endogenous SCF levels were four-fold greater than the dam (fetus ~ 2500 pg/ml, dam ~ 500 pg/ml), whereas circulating G-CSF was similar in the fetal/maternal compartments (~ 50-100 pg/ml). There were no adverse effects detected in the fetus or dam as a result of SCF ± G-CSF administration. Although high levels of SCF and G-CSF were achieved in the maternal circulation with maternal administration (SCF: 7000-15,000 pg/ml; G-CSF: 7000-54,000 pg/ml), there was little evidence of placental transport or effects on fetal haematopoiesis. In contrast, direct fetal administration of SCF + G-CSF resulted in a rapid rise in fetal neutrophil counts. These studies have shown the monkey to be an excellent model for studying haematopoietic interventions during gestation, and suggest the best approach for achieving haematopoietic changes in the fetus and newborn is by direct in utero administration.",
keywords = "Fetus, G-CSF, Haematopoiesis, Monkey, SCF",
author = "Tarantal, {Alice F} and Cowan, {Morton J.}",
year = "1999",
doi = "10.1006/cyto.1998.0420",
language = "English (US)",
volume = "11",
pages = "290--300",
journal = "Cytokine",
issn = "1043-4666",
publisher = "Academic Press Inc.",
number = "4",

}

TY - JOUR

T1 - Administration of recombinant human stem cell factor (rhSCF) and granulocyte-colony stimulating factor (rhG-CSF) to maternal and fetal rhesus monkeys (Macaca mulatta)

AU - Tarantal, Alice F

AU - Cowan, Morton J.

PY - 1999

Y1 - 1999

N2 - Studies with recombinant human stem cell factor (rhSCF) and granulocyte-colony stimulating factor (rhG-CSF) have suggested significant clinical utility although little is known regarding the effect of these cytokines when administered during pregnancy. rhSCF (25 ug/kg/day) ± rhG-CSF (50 μg/kg/day) were administered chronically to gravid rhesus monkeys (n = 12) or directly to the rhesus fetus (n = 2) during the second and third trimesters. Maternal/fetal blood samples were collected to assess circulating SCF/G-CSF levels and complete blood counts compared to non-treated animals (n = 40). Fetal endogenous SCF levels were four-fold greater than the dam (fetus ~ 2500 pg/ml, dam ~ 500 pg/ml), whereas circulating G-CSF was similar in the fetal/maternal compartments (~ 50-100 pg/ml). There were no adverse effects detected in the fetus or dam as a result of SCF ± G-CSF administration. Although high levels of SCF and G-CSF were achieved in the maternal circulation with maternal administration (SCF: 7000-15,000 pg/ml; G-CSF: 7000-54,000 pg/ml), there was little evidence of placental transport or effects on fetal haematopoiesis. In contrast, direct fetal administration of SCF + G-CSF resulted in a rapid rise in fetal neutrophil counts. These studies have shown the monkey to be an excellent model for studying haematopoietic interventions during gestation, and suggest the best approach for achieving haematopoietic changes in the fetus and newborn is by direct in utero administration.

AB - Studies with recombinant human stem cell factor (rhSCF) and granulocyte-colony stimulating factor (rhG-CSF) have suggested significant clinical utility although little is known regarding the effect of these cytokines when administered during pregnancy. rhSCF (25 ug/kg/day) ± rhG-CSF (50 μg/kg/day) were administered chronically to gravid rhesus monkeys (n = 12) or directly to the rhesus fetus (n = 2) during the second and third trimesters. Maternal/fetal blood samples were collected to assess circulating SCF/G-CSF levels and complete blood counts compared to non-treated animals (n = 40). Fetal endogenous SCF levels were four-fold greater than the dam (fetus ~ 2500 pg/ml, dam ~ 500 pg/ml), whereas circulating G-CSF was similar in the fetal/maternal compartments (~ 50-100 pg/ml). There were no adverse effects detected in the fetus or dam as a result of SCF ± G-CSF administration. Although high levels of SCF and G-CSF were achieved in the maternal circulation with maternal administration (SCF: 7000-15,000 pg/ml; G-CSF: 7000-54,000 pg/ml), there was little evidence of placental transport or effects on fetal haematopoiesis. In contrast, direct fetal administration of SCF + G-CSF resulted in a rapid rise in fetal neutrophil counts. These studies have shown the monkey to be an excellent model for studying haematopoietic interventions during gestation, and suggest the best approach for achieving haematopoietic changes in the fetus and newborn is by direct in utero administration.

KW - Fetus

KW - G-CSF

KW - Haematopoiesis

KW - Monkey

KW - SCF

UR - http://www.scopus.com/inward/record.url?scp=0033119751&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033119751&partnerID=8YFLogxK

U2 - 10.1006/cyto.1998.0420

DO - 10.1006/cyto.1998.0420

M3 - Article

VL - 11

SP - 290

EP - 300

JO - Cytokine

JF - Cytokine

SN - 1043-4666

IS - 4

ER -